Skip to main content
Log in

Cobalamin Deficiency Can Mask Depleted Body Iron Reserves

  • Original Article
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

Vitamin B12 deficiency impairs DNA synthesis and causes erythroblast apoptosis, resulting in anaemia from ineffective erythropoiesis. Iron and cobalamin deficiency are found together in patients for various reasons. We have observed that cobalamin deficiency masks iron deficiency in some patients. We hypothesised that iron is not used by erythroblasts because of ineffective erythropoiesis due to cobalamin deficiency. Therefore, we aimed to demonstrate that depleted iron body reserves are masked by cobalamin deficiency. Seventy-five patients who were diagnosed with cobalamin deficiency were enrolled in this study. Complete blood counts and serum levels of iron, unsaturated iron binding capacity (UIBC), ferritin, vitamin B12, and thyroid stimulant hormone were determined at diagnosis and after cobalamin therapy. Patients who had a combined deficiency at diagnosis and after cobalamin therapy were recorded. Before cobalamin therapy, we found increased serum iron levels (126.4 ± 63.4 µg/dL), decreased serum UIBC levels (143.7 ± 70.8 µg/dL), increased serum ferritin levels (192.5 ± 116.4 ng/mL), and increased transferrin saturation values (47.2 ± 23.5 %). After cobalamin therapy, serum iron levels (59.1 ± 30 µg/dL), serum ferritin levels (44.9 ± 38.9 ng/mL) and transferrin saturation values (17.5 ± 9.6 %) decreased, and serum UIBC levels (295.9 ± 80.6 µg/dL) increased. Significant differences were observed in all values (p < 0.0001). Seven patients (9.3 %) had iron deficiency before cobalamin therapy, 37 (49.3 %) had iron deficiency after cobalamin therapy, and a significant difference was detected between the proportions of patients who had iron deficiency (p < 0.0001). This study is important because insufficient data are available on this condition. Our results indicate that iron deficiency is common in patients with cobalamin deficiency, and that cobalamin deficiency can mask iron deficiency. Therefore, we suggest that all patients diagnosed with cobalamin deficiency should be screened for iron deficiency, particularly after cobalamin therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. McNamee T, Hyland T, Harrington J, Cadogan S et al (2013) Haematinic deficiency and macrocytosis in middle-aged and older adults. PLoS ONE 8:e77743. doi:10.1371/journal.pone.0081102

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Hvas AM, Nexo E (2006) Diagnosis and treatment of vitamin B12 deficiency—an update. Haematologica 91:1506–1512

    CAS  PubMed  Google Scholar 

  3. Koury MJ, Price JO, Hicks GG (2000) Apoptosis in megaloblastic anemia occurs during DNA synthesis by a p53-independent, nucleoside-reversible mechanism. Blood 96:3249–3255

    CAS  PubMed  Google Scholar 

  4. Atrah HI, Davidson RJL (1988) Iron deficiency in pernicious anaemia: a neglected diagnosis. Postgrad Med J 64:110–111

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Remacha AF, Sardà MP, Canals C, Queraltò JM et al (2013) Combined cobalamin and iron deficiency anemia: a diagnostic approach using a model based on age and homocysteine assessment. Ann Hematol 92:527–531. doi:10.1007/s00277-012-1634-8

    Article  CAS  PubMed  Google Scholar 

  6. Pflipsen MC, Oh RC, Saguil A, Seebusen D et al (2009) The prevalence of vitamin B12 deficiency in patients with type 2 diabetes: a cross-sectional study. JABFM 22:528–534

    Article  PubMed  Google Scholar 

  7. Koury MJ, Ponka P (2004) New insights into erythropoiesis: the roles of folate, vitamin B12, and iron. Annu Rev Nutr 24:105–131

    Article  CAS  PubMed  Google Scholar 

  8. Demiroğlu H, Dündar S (1997) Pernicious anaemia patients should be screened for iron deficiency during follow up. N Z Med J 110:147–148

    PubMed  Google Scholar 

  9. Khanduri U, Sharma A (2007) Megaloblastic anaemia: prevalence and causative factors. Natl Med J India 20:172–175

    PubMed  Google Scholar 

  10. Bessman D (1977) Erythropoiesis during recovery from macrocytic anemia: macrocytes, normocytes, and microcytes. Blood 50:995–1000

    CAS  PubMed  Google Scholar 

  11. Hillman RS, Adamson J, Burka E (1968) Characteristics of vitamin B12 correction of the abnormal erythropoiesis of pernicious anemia. Blood 31:419–432

    CAS  PubMed  Google Scholar 

  12. Gafter-Gvili A, Prokocimer M, Breuer W, Cabantchik IZ, Hershko C (2004) Non-transferrin-bound serum iron (NTBI) in megaloblastic anemia: effect of vitamin B(12) treatment. Hematol J 5:32–34

    Article  CAS  PubMed  Google Scholar 

  13. Remacha AF, Bellido M, García-Die F, Marco N et al (1997) Serum erythropoietin and erythroid activity in vitamin B12 deficiency. Haematologica 82:67–68

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

None.

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Soner Solmaz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Solmaz, S., Özdoğu, H. & Boğa, C. Cobalamin Deficiency Can Mask Depleted Body Iron Reserves. Indian J Hematol Blood Transfus 31, 255–258 (2015). https://doi.org/10.1007/s12288-014-0417-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-014-0417-x

Keywords

Navigation